1 R61 AT009333-01 3 ZAT1 SM (41) HECHT, F cravings for high carbohydrate or sugar-laden foods in an environment where these foods are tempting and widely available. One mechanism by which mindfulness may increase long-term dietary adherence is by better equipping individuals with skills to experience food cravings and difficult emotions without eating in response. Such approaches seek to strengthen abilities to be non-judgmentally aware of, tolerate, and respond skillfully to food cravings and difficult emotions without reacting impulsively or maladaptively. We hypothesize that improved ability to manage food cravings and emotional eating is a key mechanism through which mindfulness-enhancements can improve dietary adherence. We will test mindfulness-based intervention (MBI) components for improving dietary adherence based on our group's recent NCCIH-funded trial testing MBI components for obesity, which showed evidence of improved fasting glucose, lipids, and potentially weight. Although the particular diet employed is not the focus of this study, we plan to use a diet with about 10% of calories from carbohydrate as: (1) it induces a low level of ketone production, which we will use as a biomarker for dietary adherence; (2) prior studies suggest it improves metabolic parameters in T2DM, including glycemic control. METHODS: We will use ecological momentary assessment (EMA) methods to measure eating in response to difficult emotions and/or food cravings. In the R61 phase, we will ensure this measure is appropriate for further testing and assess the impact of the MBI components on our hypothesized behavioral mechanisms in N=45 persons with T2DM. We plan 3 waves of 15 persons each with 12 weekly sessions. All participants will attend an in-person group course providing education on basic behavioral strategies for diet and physical activity. Participants will be randomized to receive this education alone (Ed) or this same material with added MBI components (Ed+MBI). We will also pilot test two levels of intensity of maintenance phase intervention (monthly group meetings alone or supplemented by individualized attention) to prepare them for R33 testing. We plan an R33 phase trial in which 120 persons with T2DM will be randomized (using a 1:2 ratio) to Ed or Ed+MBI conditions and followed for 12 months, including a 9-month maintenance phase. We will test the robustness of the effect of MBI components on our proposed behavioral mechanisms, and on dietary adherence, as well as preliminary effect sizes? on weight and glycemic control. We will use an innovative adaptive intervention design to optimize maintenance phase intensity, which we believe may be key to augment the MBI effects. SIGNIFICANCE: Our studies promise to extend our understanding of how MBIs can improve dietary adherence and have broader implications for understanding the mechanisms of MBIs for other conditions such as addiction.
PUBLIC HEALTH RELEVANCE
Maintaining a healthy lifestyle is central to managing Type 2 Diabetes (T2DM), but long-term adherence to dietary recommendations is difficult. Building on our earlier trial testing a mindfulness-based intervention for weight loss, we plan to optimize and test a mindfulness-based intervention for management of T2DM, with the aim of improving tools to support people with T2DM in following a healthy lifestyle.
CRITIQUE 1:
Significance: 2 Investigator(s): 1 Innovation: 3 Approach: 4 Environment: 1
Overall Impact: R61: The R61 will test the "ability to adaptively experience food cravings" as the central mechanism whereby mindfulness skills enhance dietary adherence.
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4 ZAT1 SM (41) HECHT, F R33: The R33 will attempt to further optimize the mechanism through the use of an adaptive intervention strategy whereby intervention intensity is adjusted based on subject response to treatment.
Summary: This is a very solid application from an experienced team of Investigators with a history of successful investigation working in an outstanding research environment. There is great potential for impact on positively enhancing non-medication treatments e.g. lifestyle interventions for type 2 diabetes, a major worldwide health problem. Further, if mindfulness is effective for enhancing capacity to resist food cravings it may be generalizable to management of addiction which is also characterized by craving and which shares some overlapping neurobiology and susceptibility to stress. There are general weaknesses related to the assessment of psychiatric history and detail related to statistical analysis that need to be addressed.
Significance:
Strengths  Type 2 diabetes mellitus and obesity are extremely important public health problems.
 A large and continually growing body of clinical research supports the use of mindfulness-based treatments for stress-related disorders.
 If the investigators achieve the study aims for the R61 and the R33, the potential of lifestyle modifications, a first-line approach to treatment of diabetes and a critical piece of more intensive diabetes treatment, will be greatly strengthened by the addition of mindfulness based treatment to conventional lifestyle modifications.
 The investigators provide ample justification and rationale for the exploratory and implementation phase of the proposed research.
Weaknesses
 No major weaknesses noted.
Investigator(s):
Strengths  The Multiple PI format with complimentary sets of experience and history of effective collaboration between the two principal investigators is a strength.
 Very qualified team with a history of working with the study population and collaboratively with one another.
 Junior members of the team have more than adequate experience to perform their study roles and the experience of working on the project will further contribute to their scientific development.
Weaknesses
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 Use of ecological momentary assessment to measure craving and stress triggered eating is novel and likely to yield more accurate data than conventional retrospective methods.
 Use of ketone monitoring as an adherence and biomarker outcome across treatment interventions is novel.
 Use of an adaptive intervention strategy in the R33 phase is novel.
Approach: Strengths
 Recruitment and retention plans are adequately described.
 The R61 will test the "ability to adaptively experience food cravings" as the central mechanism whereby mindfulness skills enhance dietary adherence. All subjects will receive diet and exercise education (Ed group) and 2/3 of the subjects will receive Ed plus the mindfulnessbased intervention (Ed + MBI). The pairing of subjective measures of craving (ecological momentary assessment) with objective measures of behavior (low calorie diet with ketone assessment; 24h dietary recall) as primary outcomes tested across time and between groups is a robust way to evaluate the proposed mechanism. These outcomes are well-described, sufficiently justified, and positioned to provide interpretable results.
 Additional assessments with delayed-discounting task and self-report questionnaires related to impulsivity, stress, and emotion-related eating further enhance the depth and breadth of information derived from the R61 phase and allow for testing of alternative hypotheses depending on the primary outcome data.
 Go/No-Go criteria are sensible and quantitative. They verify the quality of the mindfulness trainer, reliability and validity of EMA, and initial impact of MBI on craving.
Weaknesses
 The subject exclusion criteria with respect to psychiatric disorders in particular are vague and rather arbitrary ("A substance abuse, mental health, or medical condition that, in the opinion of investigators, will make it difficult for the potential participant to participate in the intervention or that may need immediate changes in medical management that will affect study outcome measures") insofar as what conditions are excluded aside from a history of bulimia or current bulimia.
 How are psychiatric disorders being assessed? There are no specialty trained mental health clinicians on the study.
 Why do the investigators not plan to assess childhood abuse/trauma and adult trauma exposure? Trauma exposure may substantially impact stress reactivity and food craving.
 Along the lines of the above comments, the investigators should consider the potential impact of medications such as atypical antipsychotics, certain anticonvulsants, and certain antidepressants that may increase appetite. Conversely, there are other medications in addition to stimulants (amphetamine salts & methylphenidate) that curtail appetite such as topirimate.
 It would also be important to consider the safety of subjects on significant doses of Beta Blockers participating in the study considering the potential for masked hypoglycemia.
 The data analysis plan, while hypothesis-driven, could use more detail in terms of correcting for multiple testing in secondary data analyses.  Location of the study in a large diverse metropolitan area enhances probability of reaching study recruitment goals.
 A letter of support from project consultant, Dr. Laura Saslow is included. 
R61 Go/No-Go Criteria:
Acceptable  Go/No-Go Criteria are in general well-defined. However, it would be helpful to have more detail about specific no-go circumstances beyond reaching the quantifiable benchmarks specified by the Go Criteria. R61 phase: The R61 phase will evaluate the impact of mindfulness-based intervention (MBI) training in addition to lifestyle education (a 10% CHO diet + physical activity) on eating triggered by a) food cravings and b) difficult emotions as measured by ecological momentary assessment (EMA app). It will also test the impact of two levels of intensity of follow-up: a) monthly group visits vs. b) individualized attention. N=45 patients with stable T2DM. Specifically, determine if 1) there is a high (90%) response rate to EMA pings (Go/No Go criteria, 80% or better); 2) the MBI affects the proposed mechanisms (food cravings); and 3) assess feasibility and acceptability of two types of maintenance phase support to ensure readiness for the R33.
R33 phase:
The R33 phase will enroll 120 T2DM patients and randomize them in a 1:2 ratio to education alone vs. education plus MBI, including a 9 month maintenance phase, using the optimized intensity of follow-up from the R61 phase. Outcomes include the EMA assessment tested in the R61, weight, and glycemic control. Specifically, the R33 aims to 1) determine whether the proposed mechanisms predict dietary adherence; 2) the MBI intervention improves dietary adherence; and 3) compare the maintenance interventions to optimize maintenance phase approaches in a future trial.
Summary: This is a well thought out project by an established team of investigators using an innovative approach for an important public health problem.
Significance:
Strengths  Type 2 DM is a chronic health condition of considerable public health importance, and its prevalence is rising.
 There is a strong body of research supporting the rationale for this project, including this team's previous work on a similar intervention in a similar population (obese subjects).
 The proposed project is likely to yield clear answers needed to advance to the next stage of research in this field.
Investigator(s):
Strengths  The investigators are well suited to conduct this project. They have demonstrated an ongoing record of accomplishments that advance their fields. The leadership approach, governance, and organizational structure are appropriate for this project.
 The investigators have experience and expertise with the intervention, study population, and research methods. They publish in high impact journals. They have experience with successfully recruiting in similar populations.
Weaknesses
Innovation:

Strengths
 Clearly identified conceptual model with testable hypotheses.
 Use of EMA, devised by a member of the project team and tested in a prior study to assess eating in response to food cravings and stress.
 Use of blood ketones to measure dietary adherence.
 Use of an adaptive intervention design to test the different maintenance phase approaches.
Weaknesses
 One study has tested MBI for T2DM patients and found similar outcomes to a standard Diabetes Self-Management Education intervention in terms of weight over 3 months. That study had a small sample size, a relatively short follow-up, and did not examine behavioral mechanisms, adherence, or evaluate long-term maintenance approaches.
Approach: Strengths
 The overall strategy, methods, and analyses are well-reasoned and appropriate to accomplish the specific aims of the project. The investigators have considered alternative strategies and potential problems.
 The underlying hypothesized mechanism of action from the R61 phase is appropriate, relevant and rigorously tested. The need for this phase is well justified.
 The investigators have clearly considered the next study following the R33 phase, and considered different options depending on the outcome of the R33 phase (testing weight and HgA1c as outcomes
Weaknesses
Environment:
Strengths 1 R61 AT009333-01
 UCSF is an exemplary research environment. The Osher Center is one of the top programs providing and evaluating mindfulness interventions.
 There is reasonable assurance that the target sample size can be enrolled in the proposed time frame. There is an adequate subject pool from San Francisco General Hospital, UCSF University Clinics, and community outreach. Dr. Hecht has experience recruiting large sample sizes for clinical studies.  2. EMA response rate of 80% or higher to ensure this is a feasible way to address eating related to cravings or difficult emotions.
 3. Assessment that the study protocol is ready for the R33.
 4. Evidence that the hypothesized mechanism is impacted by the mindfulness intervention as shown by a significant decrease in craving-related eating from baseline to 12-week follow-up. If not, there must be significant improvement on at least 2/5 other measures in the MBI compared with no MBI group to proceed to the R33.
R33 Milestones:
Outstanding  Timelines and milestones for both phases are clearly described in detail.
 Plans for sample size and timely recruitment are feasible.
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Biohazards:
Not Applicable (No Biohazards)
Resource Sharing Plans:
Acceptable  The last six months of the R33 period will be used in part to prepare a deidentified data set for data sharing.
Budget and Period of Support:
Recommend as Requested R61 phase: The team addresses an important public health problem. The investigators show a strong history of working together. They are productive and experts in the field. The environment is appropriate for the type and scope of study. There are several innovative aspects to the project. However, there are a few concerns that may limit the impact on scientific knowledge. Concerns about the theoretical framework of the hypotheses and the choice of the study population and sample size calculations dampen enthusiasm. The rationale for the key measure of mechanism (in the analytic plan and the Go/No-Go criteria) is weak and may have limited relevance for this particular patient group. R33 phase: As above; a few concerns about the approach limit enthusiasm for the project, including concerns about feasibility of dietary data collection for participants, blinding, randomization, and theoretical framework.
Significance:
Strengths  The team addresses an important public health problem with considerable associated health care costs (Type 2 diabetes).
 If successful, the project could provide important information about a supplemental treatment for diabetes (and obesity).
Weaknesses
 The application notes the "critical importance of developing sustainable approaches to lifestyle intervention in T2DM" citing a study showing 'faded' results from a 1 year trial at follow-up 1 R61 AT009333-01 11 ZAT1 SM (41) HECHT, F several years later; however, the proposed project collects data only 1 year out from the start of treatment; it would be better if a longer-term outcome is planned.
Investigator(s):
Strengths  Dr. Hecht is the Director of Research, University of California San Francisco Osher Center for
Integrative Medicine and has considerable CAM clinical research experience, including a pilot study of mindfulness approaches with type 2 diabetes patients.
 Dr. Peel has extensive experience in research on interactions between psychological stress, eating, metabolism, fat distribution, and cellular aging, although not necessarily with patients with type 2 diabetes.
 The investigative team has a track record of working together and successfully completing projects and publishing results.
 The team contains an endocrinologist with expertise with T2DM.
Weaknesses
 No major concerns noted.
Innovation:
Strengths  The adaptive intervention design is innovative and a great strength.
 The EMA data collection procedure is innovative.
 Use of a carbohydrate restricted diet is a strength, given that this strategy has been gaining support in the diabetes and obesity research community.
Weaknesses
 Using mindfulness-based interventions in diabetes is not innovative.
 Using mindfulness-based interventions to regulate cravings and/or stress reduction is not innovative.
Approach: Strengths
 No major strengths noted.
Weaknesses
 The key mechanistic variable central to the project is participants' "ability to adaptively experience food cravings" (not indulge in them). This assumes that cravings are the primary source of dietary indiscretions in T2DM, that people can recognize when they are having a craving, and that people can accurately report when they ate food because of a craving (the EMA phone tool asks participants, "Did you eat or drink anything in response to a craving today?"). Evidence is not provided to support the idea that indulging cravings is the primary reason for dietary indiscretions in T2DM; in fact, the cited qualitative study lists 12 types of problems, only one of which is 'resisting temptation.' Also, ability to identify cravings may vary widely, and participants may define 'craving' differently than the investigators.
 The mindfulness intervention may not be a good match for the population; the application states that it is based on Dr. Jean Kristeller's intervention which was originally designed for binge 1 R61 AT009333-01 12 ZAT1 SM (41) HECHT, F eating disorder. It is not clear whether the psychological processes relating to eating are similar between binge eating disorder and T2DM. Given the concern about the target population above, one wonders if an overweight or disordered eating population would be a better fit for this project.
 There is a concern about the rationale for the target population given the main health outcome measurements; the application states that the Carbohydrate Restricted diet is helpful for glucose control and to lose weight. However, the inclusion criteria say nothing concrete about including participants with poorly controlled diabetes (HbA1c>8) or with an overweight or obese status. It would make more sense if the study targeted individuals with poorly controlled diabetes, for whom a change in HbA1c would be a perfect outcome measure. Alternatively, the investigators could target people with T2DM who are overweight. As it is currently written, weight loss is an outcome measure, but participants can be normal weight; is weight loss a goal in these people?
 The additional materials provided do not clearly describe how the participants report dietary intake data. In the SHINE manual provided, the instructor asks participants to count calories, but does not talk about carbohydrates. The instructions are that participants should pull out calorie counter booklets and calculate calories for each food item; are participants also going to have to report kcal from carbohydrates (the main outcome variable)? This seems difficult for participants.
 Blinding is not adequately addressed; study staff collecting data should be blinded to treatment allocation and participants should be blinded to study team hypothesis (please see https://nccih.nih.gov/research/blog/effective-blinding-plan)  The power calculation for the R61 is not entirely clear. How did the team decide that a reduction from 50% craving-eating days to 44% craving-eating days is clinically meaningful? Why is the unit days instead of craving-eating incidents? A one-sided test doesn't seem appropriate, since it is possible that the MBI has an opposite effect than expected (e.g., increasing body awareness ends up increasing awareness of craving, and thus more craving-eating).
 If participants are randomized by individual, and randomization is done in waves, then both interventions must be happening at the same time (needs clarification). Will the Ed portion of the class be mixed participants? if so, the team needs to address possible bleed (participants sharing the MBI across intervention arms).
Environment:
Strengths  Evidence of prior collaboration is provided. Sites have a scientific environment with previous project completion success.
 Adequate laboratory equipment and other physical resources are available.
Weaknesses
 The team included screen shots for the EMA system for collecting data on craving-eating.
These appear to depend on Smartphone capability; for example, in one part, participants move a virtual knob on a continuous measure between "not at all stressed" and "extremely stressed." There is no evidence provided about the percentage of people in the target population who have smartphones, and how this (in essence) inclusion criteria will affect enrollment feasibility.
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13 ZAT1 SM (41) HECHT, F  It is a strength that the team is addressing the possibility of hypoglycemia from patients' regular medication regimen of sulfonylureas or insulin. Will study physicians meet with each patient taking diabetes medications before the weekly class, for the entire 12 weeks? This seems important, to monitor medication changes (and home blood glucose measures).
 Participants are instructed to speak to the instructor if they experience dizziness, constipation, diarrhea, weakness, muscle cramps, and that they will be told that their participation is voluntary and that they can withdraw from the study. The team should clarify that participants will have access to an MD to discuss these medical symptoms. R61 phase: The applicants propose conducting a R61 trial to compare the effects of Mindfulness + Education (n=30) versus Education only (n=15) in the Type 2 diabetic population. The intervention period is 12 weeks and there are assessments at 0, 3 and 6 months. The goal of the R61 phase is to extend this successfully used intervention in obese but not type 2 diabetic patients. Significant enhancements to the prior studies include use of Ecological Momentary Assessment, the use of a calorie restricted diet for all ED and MBI + ED subjects thereby allowing for an objective measure of blood ketone monitoring to assess compliance with the restricted diet and the innovative use of an adaptive intervention in the MBI+ED group to optimize the maintenance strategy. Overall this portion of the application is carefully prepared and generates a lot of enthusiasm. There are minor issues: The Education group does not appear to have equal attention from investigators or home practice, there seem to be no measures of expectancy, and individual subjects will not have their treatment assignment masked. The Education group may feel less compelled to comply with the study or complete the study if they are aware of the other group receiving more training. The principal investigator and the team have the requisite knowledge to conduct the proposed study, and there is sufficient confidence that the proposed study would provide results necessary to move to the R33 phase and that the Go-No Go criteria are clearly described.
Data and Safety
R33 phase:
The applicants propose a randomized trial to compare the effects of Mindfulness + Education (n=80) versus Education only (n=40) in a Type 2 diabetic population. Results of the R61 will provide preliminary data on the mechanism related measures and maintenance strategies for use in the R33. The follow-up period in the R33 will be 1 year. There is a possible issue with the Education group failing to complete the study with the long-follow-up period. Expectancy and blinding/masking are minor issues.
Summary: This is a very innovative project from a strong investigative team at a stellar university setting. Given only minor issues, there is great enthusiasm for the applicaiton as written.
CRITIQUE 5:
Overall Impact:
The study design seems reasonable. The analysis plan is very general and vague and does not clearly map to aims and hypotheses. There are many measures being collected in this study and a couple of randomization points; the project could be strengthened by more clearly mapping hypotheses to analysis methods. The Go/No-Go criteria are detailed although criteria for the maintenance phase intervention seem subjective. It was unclear whether mindfulness sessions are held by the same instructor and if group session compositions will always be the same individuals -leading to the potential of a clustering effect that may be unaccounted for in the analysis. Consideration of stratification variables for randomization should be noted for both the R61 and the R33. For R61 analysis plan:
o One sided tests are not really appropriate for the sake of improving power. Assuming that a t-test was the method for sample size calculation but this was not explicitly stated. o The study design is not clearly accounted for in the analysis plan. It is unclear how the EMA nature of the data is accounted for in the analysis although it states general use of mixed models for secondary analyses. o The study design is not well accounted for in the analysis plan, there is mention of a SMART trial but this is not reflected in the analysis plan. o In the Milestone section for the R33 section, it states specifically that primary analysis for diet adherence is the proportion of keystone measures above threshold. Justification needs to be given for this as an outcome and the clinical meaning of this. Ketone data is collected daily for several weeks and then twice monthly. The analysis should reflect this design. The use of t-test at specific time points for the main comparisons is rather inefficient. More thought and detail needs to be given to the analysis. o Sample size calculation does not clearly reflect design and does not map very well to primary aims detailed for the R33. Footnotes for 1 R61 AT009333-01; PI Name: Hecht, Frederick M NIH has modified its policy regarding the receipt of resubmissions (amended applications). See Guide Notice NOT-OD-14-074 at http://grants.nih.gov/grants/guide/notice-files/NOT-OD-14-074.html. The impact/priority score is calculated after discussion of an application by averaging the overall scores (1-9) given by all voting reviewers on the committee and multiplying by 10. The criterion scores are submitted prior to the meeting by the individual reviewers assigned to an application, and are not discussed specifically at the review meeting or calculated into the overall impact score. Some applications also receive a percentile ranking. For details on the review process, see http://grants.nih.gov/grants/peer_review_process.htm#scoring. 
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